Hongling Jia
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Research Subjects
Hongling Jia has a total of 5 co-authors. Here are the top co-authors by number of shared publications:
- Wenwu Li
Department of Burn Plastic and Wound Repair Surgery, Affiliated Hospital of Youjiang Medical University for Nationalities, Baise, China
1 shared publication - Yuelong Qin
College of First Clinical Medicine, Shandong University of Traditional Chinese Medicine, Jinan, China
1 shared publication - Zhenzhen Zhao
The First Clinical Medical College, Shandong University of Traditional Chinese Medicine, Jinan, Shandong, China
1 shared publication - Zhijie Zhao
Department of Plastic and Reconstructive Surgery Shanghai Ninth People's Hospital, Shanghai Jiao Tong University School of Medicine Shanghai China
1 shared publication - Zhikai Xiahou
China Institute of Sport and Health Science, Beijing Sport University, Beijing, China
1 shared publication
Latest Publications
- Open Access
- 25 February 2026
- Published by Springer Nature in Clinical and Experimental Medicine
- Vol. 26 (1) , 170
Exploring immune-inflammatory cross-talk in atherosclerosis using AI-enhanced multi-omics approaches
Atherosclerosis is a complex chronic inflammatory disease characterized by lipid accumulation, vascular smooth muscle cell (VSMCs) proliferation, and immune cell infiltration. However, the heterogeneity and functional dynamics of VSMCs in atherosclerotic lesions have not been systematically elucidated. In this study, we integrated single-cell transcriptomics with spatial transcriptomics analysis to delineate the developmental trajectories and functional states of VSMC subsets. Our analysis identified a distinct LUM + VSMCs subpopulation residing at an early stage of differentiation, marked by elevated cellular plasticity, stemness features, and strong activation of pro-inflammatory signaling pathways. Spatial transcriptomics and in vitro functional assays—including EdU incorporation, apoptosis quantification, and cell viability assays—further validated LUM as a key regulator promoting VSMC proliferation and inflammation. Importantly, the C0 LUM + VSMCs were predicted to interact extensively with endothelial cells and macrophages through CD99, MIF, and CCL-mediated signaling axes, underscoring their role as dedifferentiated, pro-inflammatory effector cells contributing to disease progression. These findings highlight the power of big data-enabled single-cell approaches in identifying cell-type–specific mechanisms and offer new avenues for precision diagnostics and biomarker discovery in inflammatory vascular diseases.
- 25 February 2026
- Published by Springer Nature in Clinical and Experimental Medicine
- Vol. 26 (1) , 170
Open AccessExploring immune-inflammatory cross-talk in atherosclerosis using AI-enhanced multi-omics approaches
Atherosclerosis is a complex chronic inflammatory disease characterized by lipid accumulation, vascular smooth muscle cell (VSMCs) proliferation, and immune cell infiltration. However, the heterogeneity and functional dynamics of VSMCs in atherosclerotic lesions have not been systematically elucidated. In this study, we integrated single-cell transcriptomics with spatial transcriptomics analysis to delineate the developmental trajectories and functional states of VSMC subsets. Our analysis identified a distinct LUM + VSMCs subpopulation residing at an early stage of differentiation, marked by elevated cellular plasticity, stemness features, and strong activation of pro-inflammatory signaling pathways. Spatial transcriptomics and in vitro functional assays—including EdU incorporation, apoptosis quantification, and cell viability assays—further validated LUM as a key regulator promoting VSMC proliferation and inflammation. Importantly, the C0 LUM + VSMCs were predicted to interact extensively with endothelial cells and macrophages through CD99, MIF, and CCL-mediated signaling axes, underscoring their role as dedifferentiated, pro-inflammatory effector cells contributing to disease progression. These findings highlight the power of big data-enabled single-cell approaches in identifying cell-type–specific mechanisms and offer new avenues for precision diagnostics and biomarker discovery in inflammatory vascular diseases.